Lakshmikumaran & Sridharan Attorneys is organizing a webinar for the Pharma Sector, to decode recent trends in Customs and GST, including GST rate for APIs, issues relating to inverted tax structure, impact of 2025 GST changes as well as developments under FEMA from October 2026 which will impact export and import trade.
The webinar will inter-alia cover:
1. Recent trends in the Pharma Industry
2. Advance rulings in relation to applicable GST rate on APIs
· Implication on imports
· Implication from GST perspective – domestic supply, exports
3. ITC accumulation and implications
4. Customs schemes re-evaluation – SEZ unit, AA, EOU, MOOWR, drawback
5. ITC reversal in relation to expired stock
6. Impact of Rule 96B
7. Discount schemes and GST impact
8. FEMA changes in relation to EXIM, effective from October 2026
9. Inter-play between Customs, GST and FEMA
10. Expectations from GST Council meeting for the sector
Speakers -
Asish Philip, Executive Partner
Srinidhi Ganeshan, Partner
Darshan Machchhar, Partner
Related Articles



Diagnosing the issues of E-pharmacies
Ahalya Chalasanil17 Jan 2019
Discuss this topic with our GST & Indirect Tax Litigation team
Contact Us
